Molecular immunology lessons from therapeutic T-cell receptor gene transfer

Immunology

Volumn 129, Issue 2, 2010, Pages 170-177

  Thomas, Sharyn ^a   Stauss, Hans J ^a   Morris, Emma C ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Lessons; Molecular immunology; T cell receptor (TCR) gene transfer

Indexed keywords

CD3 ANTIGEN; LENTIVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; RETROVIRUS VECTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN SPECIFICITY; CODON; DIMERIZATION; GENE SEQUENCE; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; VIRUS INFECTION;

ANIMALS; COMMUNICABLE DISEASES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOTHERAPY, ADOPTIVE; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

EID: 73949100822     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03227.x     Document Type: Review

References (48)

1. Clay TM, Custer MC, Sachs J et al. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J Immunol 1999 163 : 507 513.
2. Cooper LJ, Kalos M, Lewinsohn DA, Riddell SR, Greenberg PD. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J Virol 2000 74 : 8207 8212.
3. Fujio K, Misaki Y, Setoguchi K et al. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex. J Immunol 2000 165 : 528 532.
4. Schaft N, Willemsen RA, de Vries J et al. Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes. J Immunol 2003 170 : 2186 2194.
5. Kessels HW, Wolkers MC, van den Boom MD, van der Valk MA, Schumacher TN. Immunotherapy through TCR gene transfer. Nat Immunol 2001 2 : 957 961.
6. Stanislawski T, Voss RH, Lotz C et al. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol 2001 2 : 962 970.
7. Morris EC, Tsallios A, Bendle GM, Xue SA, Stauss HJ. A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection. Proc Natl Acad Sci USA 2005 102 : 7934 7939.
8. Morgan RA, Dudley ME, Wunderlich JR et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006 314 : 126 129.
9. Qasim W, Mackey T, Sinclair J et al. Lentiviral vectors for T-cell suicide gene therapy: preservation of effector function after cytokine-mediated transduction. Mol Ther 2007 15 : 355 360.
10. Cavalieri S, Cazzaniga S, Geuna M et al. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 2003 102 : 497 505.
11. Call ME, Wucherpfenning KW. The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu Rev Immunol 2005 23 : 101 125.
12. Cohen CJ, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA. Enhanced antitumor activity of murine-human hybrid t-cell receptor (tcr) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res 2006 66 : 8878 8886.
13. Labrecque N, Whitfield LS, Obst R, Waltzinger C, Benoist C, Mathis D. How much TCR does a cell need? Immunity 2001 15 : 71 82.
14. Scholten KB, Kramer D, Kueter EW et al. Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells. Clin Immunol 2006 119 : 135 145.
15. de Witte MA, Jorritsma A, Kaiser A et al. Requirements for effective antitumor responses of TCR transduced T cells. J Immunol 2008 181 : 5128 5136.
16. Jorritsma A, Gomez-Eerland R, Dokter M et al. Selecting highly affine and well-expressed TCRs for gene therapy of melanoma. Blood 2007 110 : 3564 3572.
17. Ghattas IR, Sanes JR, Majors JE. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol 1991 11 : 5848 5859.
18. Yang S, Cohen CJ, Peng PD et al. Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Ther 2008 15 : 1411 1423.
19. Leisegang M, Engels B, Meyerhuber P et al. Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. J Mol Med 2008 86 : 573 583.
20. Heemskerk MH, Hagedoorn RS, van der Hoorn MA et al. Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood 2007 109 : 235 243.
21. Sommermeyer D, Neudorfer J, Weinhold M et al. Designer T cells by T cell receptor replacement. Eur J Immunol 2006 36 : 3052 3059.
22. Thomas S, Xue SA, Cesco-Gaspere M et al. Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells. J Immunol 2007 179 : 5803 5810.
23. Falkenburg WJJ, Melenhorst JJ, Kester MGD et al. Allogeneic HLA-A2-restricted WT1-specific T cells from mismatched donors are highly reactive but show potentially hazardous promiscuity. Blood (ASH Annual Meeting Abstracts) 2009 114 : 4081.
24. Kuball J, Dossett ML, Wolfl M et al. Facilitating matched pairing and expression of TCR chains introduced into human T cells. Blood 2007 109 : 2331 2338.
25. Cohen CJ, Li YF, El-Gamil M, Robbins PF, Rosenberg SA, Morgan RA. Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Res 2007 67 : 3898 3903.
26. Voss RH, Willemsen RA, Kuball J et al. Molecular design of the Calphabeta interface favors specific pairing of introduced TCRalphabeta in human T cells. J Immunol 2008 180 : 391 401.
27. Zhang T, He X, Tsang TC, Harris DT. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function. Cancer Gene Ther 2004 11 : 487 496.
28. Sebestyen Z, Schooten E, Sals T et al. Human TCR that incorporate CD3zeta induce highly preferred pairing between TCRalpha and beta chains following gene transfer. J Immunol 2008 180 : 7736 7746.
29. van der Veken LT, Hagedoorn RS, van Loenen MM, Willemze R, Falkenburg JH, Heemskerk MH. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity. Cancer Res 2006 66 : 3331 3337.
30. van der Veken LT, Coccoris M, Swart E, Falkenburg JH, Schumacher TN, Heemskerk MH. Alpha beta T cell receptor transfer to gamma delta T cells generates functional effector cells without mixed TCR dimers in vivo. J Immunol 2009 182 : 164 170.
31. Hiasa A, Nishikawa H, Hirayama M et al. Rapid alphabeta TCR-mediated responses in gammadelta T cells transduced with cancer-specific TCR genes. Gene Ther 2009 16 : 620 628.
32. Gao L, Bellantuono I, Elsasser A et al. Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood 2000 95 : 2198 2203.
33. Xue SA, Gao L, Hart D et al. Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells. Blood 2005 106 : 3062 3067.
34. Kuball J, Schmitz FW, Voss RH et al. Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity 2005 22 : 117 129.
35. Chlewicki LK, Holler PD, Monti BC, Clutter MR, Kranz DM. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J Mol Biol 2005 346 : 223 239.
36. Holler PD, Holman PO, Shusta EV, O'Herrin S, Wittrup KD, Kranz DM. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc Natl Acad Sci USA 2000 97 : 5387 5392.
37. Holler PD, Monti BC, Clutter MR, Kranz DM. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J Mol Biol 2005 346 : 223 239.
38. Li Y, Moysey R, Molloy PE et al. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat Biotechnol 2005 23 : 349 354.
39. Weber KS, Donermeyer DL, Allen PM, Kranz DM. Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proc Natl Acad Sci USA 2005 102 : 19033 19038.
40. Varela-Rohena A, Molloy PE, Dunn SM et al. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med 2008 14 : 1390 1395.
41. Valtutti S, Muller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T cell receptors by a few peptide-MHC complexes. Nature 1995 375 : 148 151.
42. Holler PD, Chlewicki LK, Kranz DM. TCRs with high affinity for foreign pMHC show self-reactivity. Nat Immunol 2003 4 : 55 62.
43. Donermeyer DL, Weber KS, Kranz DM, Allen PM. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy. J Immunol 2006 177 : 6911 6919.
44. Zhao Y, Bennett AD, Zheng Z et al. High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol 2007 179 : 5845 5854.
45. Robbins PF, Li YF, El-Gamil M et al. Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. J Immunol 2008 180 : 6116 6131.
46. Kuball J, Hauptrock B, Malina V et al. Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain. J Exp Med 2009 206 : 463 475.
47. Tsang JY, Tanriver Y, Jiang S et al. Conferring indirect allospecificity on CD4+ CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest 2008 118 : 3619 3628.
48. Wright GP, Notley CA, Xue SA et al. Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proc Natl Acad Sci USA 2009 106 : 19078 19083.